Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The investigators propose to develop and adapt \'ANZEILAX\' smartphone app specifically for individuals with Generalized anxiety disorder. The study will measure the therapeutic effects and safety of \'ANZEILAX\' on symptoms of anxiety using pre- and post-treatment scores for generalized anxiety disorder and other physical, emotional, and cognitive symptoms of anxiety
Epistemonikos ID: 232c71343b48eb36a8f30a3850e7e7e5a12bc3ee
First added on: May 15, 2024